Our founders believe that better and earlier diagnosis will result in much better health outcomes than the best therapeutics used at a later stage of a disease.

Leadership Team

Roya Khosravi-Far, PhD, PLD

President & Chief Executive Officer
Translational Medicine
Oncology & Infectious Diseases

Reza Mollaaghababa, Ph.D., J.D.

Chief Strategist

Carlos Aparicio, Ph.D.

Chief Operating Officer
Medical Device Developer

Rich Devito, M.S.

Vice President of Engineering

Board of Directors and Scientific and Clinical Board

Zeid Barakat, MBA

Board of Directors
Partner, Scimitar Inc.

Raphael Nir, Ph.D.

Medical/Scientific Board
Angel Investor
President, SBH Diagnostics

Ali Shazib, DMD

Medical/Scientific Board
Chief Clinical Officer

Roya Zandparsa, DDS, MSc, DMD, FICD

Medical/Scientific Board

Stefan Riedel, Ph.D., M.D.

Medical/Scientific Board
Molecular Diagnostic

Collaborators

Ariel Furst, Ph.D.

Assistant Professor
Chemical Engineering
Massachusetts Institute of Technology

Fatemeh Emdad, Ph.D.

Professor, Computer Science
Data Science
Worcester Polytechnic Institute